AI Article Synopsis

  • - The outpatient oncology-monitoring program aims to improve patient care by reorganizing practices within clinical departments and enhancing monitoring through pre-chemotherapy patient calls conducted by specialized nurses.
  • - In the first three months of implementation, the program involved 382 patients, achieving an 87% completion rate for clinical questionnaires and significantly improving early drug preparation rates from 0% to 40% for expensive drugs.
  • - Preliminary results indicate high patient compliance and a decrease in wastage of chemotherapy preparations; however, further studies are needed to assess satisfaction and optimize operational efficiency in the long run.

Article Abstract

Introduction: The development of outpatient departments requires health professionals to reorganize practices for a better patient monitoring and a better patient care pathway.

Objective: To evaluate, using indicators, the impact of an oncology-monitoring program on activity and organizational fluidity in a Cytotoxic Preparation Unit and clinical departments. Method the clinical and biological data are collected between two injections by calling the patient two days prior chemotherapy is performed by a specialist nurse of an outsourced medical call center. After medical and pharmaceutical validation, early preparations (D-1) for expensive and non-expensive molecules are performed.

Results: The program is started in February 2016. After 3 months, 382 patients were included into the program. Twenty-three patients on average are called per day related to 1162 completed clinical questionnaires (87%). Among the files, 47% are complete at D-2 (biological and clinical data). The early preparation rate of expensive drugs, zero before the program for financial reasons, has reached 40% at 3 months. The destroyed preparation rate because of non-administration decreased from 5 to 2%.

Discussion: Preliminary results show a significant patient compliance, feasibility of early preparation of expensive and non-expensive chemotherapy. These are preliminary results of a one-year study. They will be completed by an evaluation of patients' and health professionals' satisfaction, evaluation of length of stay, optimization of operations for clinical departments and CPU. The D-2 biological data collection must be improved. A strong doctor/pharmacist collaboration is essential for better patient care pathway.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.01.010DOI Listing

Publication Analysis

Top Keywords

better patient
12
oncology-monitoring program
8
patient care
8
clinical departments
8
biological data
8
expensive non-expensive
8
d-2 biological
8
early preparation
8
preparation rate
8
program
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!